XOM

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.26%

Status

scored

Maintain XOM at benchmark weight with active trigger discipline rather than passive hold; use $165 protective puts to hedge the binary Q3 earnings catalyst weeks away; trim 5-10% on SPY-relative underperformance exceeding 0.3% over 3 sessions. The synthesis holds that structural tailwinds (Guyana/Permian/LNG, fortress 0.47x net debt/EBITDA balance sheet, Aaa rating, 42-year dividend) anchor the downside while Polymarket-de-rated crude and tested $169.32 resistance cap the upside, making pre-committed trigger architecture superior to directional pre-positioning.

Outcome

✗

Return

+2.71%

Status

scored

Maintain XOM at benchmark weight with active trigger discipline, neither adding ahead of the binary Q3 2026 earnings catalyst nor trimming preemptively given the fortress balance sheet (0.47x net debt/EBITDA, Aaa rating, 42-year dividend streak). Hard stop is $157.50; trim 10-15% (not 25-50%) on tightened SPY-relative underperformance of >0.3% over 3 sessions; optional tactical overlays include cash-secured puts at $150-155 strike or call spreads $170-180 to convert uncertainty into bounded-risk positioning.

Outcome

✓

Return

-0.26%

Status

scored

Maintain XOM at $164.48 with active trigger discipline rather than passive holding, as the HOLD rating balances a fortress balance sheet (0.47x Net Debt/EBITDA, A+/A1 credit, 42-year dividend streak) anchoring the structural floor against 5 consecutive sessions of 0.3-0.7% alpha bleed versus SPY and overhead supply at $168-170 blocking upside. Pre-committed mechanical triggers for both upgrade to Overweight (breakout above $169.32 with volume/MACD confirmation and SPY-relative basing) and downgrade to Underweight (SPY-relative underperformance >0.5% over 3-5 sessions triggers 10-15% trim), with Q3 2026 earnings in mid-October serving as the binding tiebreaker.

Outcome

–

Return

+0.29%

Status

scored

Build toward 1.25-1.5x benchmark weight in XOM over 2-4 weeks via a scaled entry strategy: 30% tranche at $160-162 (50 SMA zone) with a hard stop at $157.50, scaling to 70% on a confirmed $160 hold for 3+ days combined with a positive MACD histogram turn, and completing the position on either a volume-confirmed breakout above $170 or a pullback to the $148-152 (200 SMA) zone. Trim 25% at $174 and another 25% at $180-185 on Q3 earnings beat, trailing the remainder with the 50 SMA. Mandatory reassessment at Q3 2026 earnings (mid-October). No protective puts; the $157.50 hard stop and trigger architecture serve as the risk management mechanism.

Outcome

✓

Return

-0.01%

Status

scored

Maintain XOM at benchmark weight with active HOLD discipline as the 1.4:1 honest risk-reward, rich 21.11x TTM P/E, and Polymarket oil repricing argue against adding, while the fortress balance sheet (0.47x net debt/EBITDA, Aaa, 42-year dividend, $20.3B buyback) argues against trimming pre-emptively. Pre-commit to trim 10-15% on SPY-relative underperformance >0.5% over 3-5 sessions or confirmed close <$158, reload on close >$169.32 with MACD positive, with Q3 2026 earnings as the binary tiebreaker.

Outcome

✓

Return

+0.12%

Status

scored

XOM holds at benchmark weight with an active HOLD rating, as both bull and bear cases remain unresolved ahead of Q3 2026 earnings. The structural floor (0.47x net leverage, Aaa rating, 42-year dividend streak) anchors the downside while fresh MACD sell cross and momentum exhaustion cap upside. Key upgrade triggers include a Q3 clean print (EPS >$3.00, FCF >$12B), a confirmed close above $169.30, or 50 SMA defense at $158-160 with MACD stabilization; downgrade triggers include weak Q3 print, confirmed close below $158 on rising volume, or XOM underperforming SPY by >0.5% over 3-5 sessions.

Outcome

✓

Return

+0.66%

Status

scored

Maintain XOM at current benchmark weight (~162.75) with a HOLD rating, awaiting Q3 earnings catalyst before any allocation changes. The fortress balance sheet (0.47x net debt/EBITDA, Aaa, 42-year dividend streak) absorbs current bearish technical signals, with pre-committed trigger architecture governing post-Q3 decisions: upgrade to Overweight if Q3 EPS exceeds $3.00 with FCF above $12B and receivables normalizing, or downgrade to Underweight with 10-15% trim if Q3 EPS falls below $2.00 or FCF drops below $8B. Hard stop set at $147 (just below 200 SMA at $147.17) on a closing basis.

Outcome

✓

Return

+0.87%

Status

scored

Maintain XOM at Hold with active discipline rather than passive neutral, given deteriorating short-term momentum (MACD histogram negative for 10 sessions, MACD line down 88%, RSI rolling over from 72) offset by fortress balance sheet (0.47x net debt/EBITDA, Aaa rating, 42-year dividend streak). Pre-committed upgrade and downgrade triggers replace passive HOLD, with Q3 2026 earnings in mid-October as the definitive tiebreaker and $146.94 (200 SMA) as the hard stop.

Outcome

–

Return

-0.72%

Status

scored

Underweight on XOM with a 15-20% trim calibrated below the research plan's magnitude because the structural floor has demonstrated reliable absorption of bearish signals, making full exit or larger reduction inappropriate. Key bearish signals include 9-session MACD histogram negativity, failed breakout at $169.32, 37.6M share distribution day, and receivables spike (+36% QoQ to $60.6B), while the $6.2B→$31.8B net debt trajectory and 200 SMA at $146.72 define the downside risk.

Outcome

✗

Return

+1.20%

Status

scored

Underweight XOM with a 20-25% trim to the $162 zone (Bollinger middle band/10 EMA resistance) while maintaining a 75-80% core position to preserve the structural floor anchored by 0.47x net debt/EBITDA, Aaa rating, 42-year dividend streak, and $20.3B buyback. Re-entry triggers are set at $159 (50 SMA defense with MACD histogram stabilization) and $162.48 (Bollinger reclaim with positive MACD), with deep re-entry at $148-150 (200 SMA) if Q3 earnings confirms EPS revision toward the bear's $8.50 base case; a $156.48 stop on residual position caps downside risk.

Outcome

✓

Return

-0.96%

Status

scored

XOM is rated HOLD at benchmark weight, with a 30% starter position recommended on a confirmed 50 SMA pullback to $158.39 with volume contraction and rejection candle, and full ADD on close above $166 with MACD histogram positive for 2+ sessions; $155 is the hard stop. The structural floor—0.47x net debt/EBITDA, 41-year dividend streak, $20.3B buyback program, and 78% Hormuz disruption odds—supports maintaining exposure while $155-strike December puts serve as standard portfolio insurance above 3% exposure (mandatory above 5%), and a 10% trim is triggered if XOM underperforms SPY by more than 0.5% over 3-5 sessions.

Outcome

✓

Return

+0.56%

Status

scored

Maintain XOM at benchmark weight at $158 with Hold rating, as the Research Manager's Overweight is functionally a Hold given limited ~6% consensus upside and fading short-term momentum after the 60%+ rally from $110. The position avoids adding into negative MACD histogram and price below the 10 EMA at $162.62, while explicit ADD/TRIM/EXIT triggers (at $162.62, $169.32, and $149 respectively) plus tightened SPY-relative discipline prevent rented-beta failure modes.

Outcome

✗

Return

+1.59%

Status

scored

Trim XOM by 20-25% at $158 via single block or covered-call execution while retaining 75-80% residual position to preserve dividend carry (~6% capital return yield), $20.3B annual buyback, and asymmetric Papua LNG/Guyana/Venezuela optionality; hard stop on residual at $161. Re-entry triggers are confirmed close above $162 on rising volume, washout to $148-150 with capitulation volume, or Q3 2026 earnings validating $10B+ FCF run-rate — the trim IS the insurance, so NO put protection is warranted.

Outcome

✓

Return

+0.26%

Status

scored

Maintain XOM at benchmark weight with no additions into momentum deterioration near the 10 EMA and no trims on weakness to $156-157; pre-commit to a 10% trim if XOM underperforms SPY by >1% over 1-2 weeks without the $155.64 TRIM trigger firing. The 0.47x net debt/EBITDA fortress floor and $20.3B annual buyback provide structural support, but the +2% probability-weighted expected return is insufficient for an upgrade given MACD histogram at -0.71, RSI collapsed to 44.86, and demand destruction signals from WTI futures.

Outcome

✓

Return

-3.20%

Status

scored

Trim XOM by 20-25% at market ($163.54) to UNDERWEIGHT given technical breakdown (MACD bearish cross, 37M volume on breakdown, price below 10 EMA at $163.96), trailing P/E of 21x (~30% above 10-year integrated oil average, peers at 11-13x), and receivables spike of 36% sequentially to $60.6B with current ratio deterioration (1.97→1.14), while maintaining 75-80% residual position with hard stop at $143 on closing basis, tiered re-entry at $155-158 (50 SMA) or $144-145 (200 SMA), and pre-committed additional 10% trim if XOM underperforms SPY by >1% over 1-2 weeks.

Outcome

✓

Return

+0.17%

Status

scored

Maintain XOM at Hold with no new exposure at $163; add only on confirmed pullback to $156-157 confluence zone (50 SMA + lower Bollinger band) with closing-basis entry, trim 10-15% on rallies to $169-170, and maintain hard stop at $145 (200 SMA) on closing basis. Dual-confirmation exit trigger requires both WTI below $95 for two consecutive weeks AND XOM below $156 before reducing exposure.

Outcome

✓

Return

-0.03%

Status

scored

Maintain existing XOM position at $163.32 without adding new exposure; set mental stop at $154 and consider trimming 10-15% on any rally to $169-170 to lock in YTD gains into seasonally weaker Q3. Re-enter only on confirmed breakout above $169.60 with 18M+ volume, or on pullback to $144-150 zone offering ~5:1 risk/reward.

Outcome

✓

Return

-3.54%

Status

scored

XOM rated Underweight with a calibrated 20-25% trim at $169 area via single block or covered-call execution. Trailing stop on residual at $164 (10 EMA close) with hard structural stop at $150 (50 SMA break). Re-entry triggers include first tranche at $155-158 with positive macro catalyst, second tranche at $144-145 as deep value, and reserve third tranche for confirmed close above $170.50 on 18M+ volume with RSI above 70. Binding reassessment gates are Q3 2026 earnings (late October) and Papua LNG FID (Q4 2026).

Outcome

✗

Return

+2.57%

Status

scored

Maintain XOM position at $165 with tighter risk management rather than chasing strength into $168-169 resistance where two breakout attempts have failed on below-average volume. Execute a tiered scaling approach—1/3 at $162-163 on confirmed bounce, 1/3 on breakout above $170 with rising volume, and reserve 1/3 for $158-160 on macro-driven pullback—with stops tightened to $159-160 and a hard structural stop at $154.50. The binding reassessment gate is Q3 2026 earnings in late October.

Outcome

✓

Return

-0.55%

Status

scored

Trim XOM by 35-40% into the $165-170 zone with a hard stop at $150 on the retained core holding, implementing tiered re-entry at $158-160 (first tranche, 10 EMA/VWMA confluence) and $153-156 (second tranche, RSI >45 and MACD histogram flattening), with Q3 2026 earnings in late October as the binding reassessment gate based on five converging bearish signals: MACD momentum divergence, elevated 21.4x P/E valuation versus below-average growth ranking, unsustainable forward EPS consensus at $10.79, exhausted institutional sentiment, and an asymmetric binary event window.

Outcome

–

Return

+0.46%

Status

scored

Trim XOM by 35-40% at current $163-167 levels due to deteriorating momentum signals including a bearish MACD cross and RSI divergence from the August peak, with hard stop at $150 on retained core. Re-enter in two tranches—first at $161-163 on 10 EMA/VWMA confluence, second at $153-158 conditional on 50 SMA test with RSI >45 and flattening MACD histogram—with a modest put overlay sized to the trimmed position. Q3 2026 earnings late October serves as the binding reassessment gate.

Outcome

✗

Return

+0.61%

Status

scored

Trim XOM 30-40% at current $164 levels to capture -$9B receivables absorption reversal risk and peak refining margins (Q2 EPS $3.48, +71% sequential swing), while retaining 60-70% for dividend carry ($17B annual) and structural floor support (0.47x net debt/EBITDA, 41-year dividend streak). Re-enter tiered at $158-160 and $155-156 with stop at $150; mandatory reassessment at Q3 2026 earnings late October.

Outcome

✗

Return

+2.22%

Status

scored

XOM rated Underweight with a 40-45% trim via two-tier execution—Tier 1 reduce 25-30% near $160-161, Tier 2 conditional additional 10-15% on failure to reclaim VWMA at $161.96 within 3-5 sessions. Hard stop at $152.79 (50 SMA). Five bearish signals drive the call: MACD bearish cross with histogram at -0.60, RSI rolling to low 50s, Q2 net income of $14.5B representing a 71% sequential swing from Q1's $4.2B signaling peak-quarter exposure, FCF collapse of 65% from 2021 peak with capital returns exceeding cash by ~$17B annually, and Polymarket geopolitical premium unwinding. Full exit rejected—structural floor of 0.47x net debt/EBITDA, 41-year dividend growth streak, $20.5B buyback, and 0.175 beta justify retaining 55-60% position. Mandatory reassessment at Q3 2026 earnings late October.

Outcome

✗

Return

+0.75%

Status

scored

Reduce XOM to below-benchmark weight based on five converging bearish signals (MACD bearish cross, geopolitical premium collapsing, peak P/E anchored to commodity-driven earnings, buybacks funded by balance sheet not cash flow, Venezuela catalyst failure). Two-tier execution: trim 20-25% now at ~$159, with conditional 10-15% trim on relief rally, hard stop at $152, and tiered re-entry at $145-150, $135-140, and $125-130. Maintain dividend and buyback as downside protection while avoiding additions before Q3 2026 earnings.

Outcome

✓

Return

-1.69%

Status

scored

Analysts recommend trimming XOM to 50-55% of current weight via a two-tranche execution: 30-35% reduction at ~$162, with an additional 15-20% trim on a $164-165 retest. Hard stop set at $150 (50 SMA at $151.83). Re-entry requires BOTH oil stabilization above $75 on a four-week basis AND formal XOM Venezuela participation confirmation or ruling-out. The Underweight rating is justified by a confirmed MACD bearish cross, unwinding geopolitical premium (Polymarket Iran/Hormuz odds collapsing from 26% to 17%), trailing P/E of 24.2x, and 2025 distributions at 158.8% of FCF, while the structural floor (0.17 beta, 41-year dividend streak, $37B capital return) precludes a full Sell.

Outcome

✓

Return

-1.18%

Status

scored

Maintain HOLD on XOM at $164 as the risk/reward asymmetry is unfavorable with only ~3-4% upside to $169-171 versus ~8% downside to the 50 SMA at $151, despite the structural floor (0.17 beta, 41-year dividend streak, $37B capital return) precluding Underweight. Do not initiate new longs or add on weakness above $162; the better entry zone is $148-152 with MACD histogram confirmation and WTI support above $80. Q3 2026 earnings in late October is the binding reassessment gate, with sub-$2.50 EPS or receivables decline from $60.6B toward $45-50B as key bear catalysts.

Outcome

✓

Return

-0.24%

Status

scored

Exxon Mobil warrants an Underweight rating with a 4-8 week tactical horizon, trimming 15-20% near $160-165 while maintaining 80-85% of benchmark weight rather than the rejected 50-60% target. The rating is supported by four key concerns—Q2 tax-rate normalization, 36% receivables spike signaling commodity-cycle working capital risk, stretched 15.5x forward P/E anchored to peak estimates, and 15.7% deviation above the 200 SMA with decelerating MACD momentum—with a hard stop at $150.42 and mandatory reassessment at Q3 2026 earnings.

Outcome

✗

Return

+2.24%

Status

scored

Maintain current XOM exposure at Hold with conditional execution discipline—the structural floor (0.16x D/E, 41-year dividend streak, $37.5B capital return) prevents Underweight conviction, but 4.4% upside to $168 versus 3.1% downside to $156 makes adding at $160.95 unfavorable; trim 15-20% only if $166-168 fails with volume, add 10-15% on pullback to $148-152 only if WTI holds above $80, with hard stop at $148 and mandatory reassessment at Q3 earnings in late October.

Outcome

✓

Return

+2.71%

Status

scored

Upgraded from Hold to Overweight based on pattern recognition that passive Hold has consistently underperformed directional conviction in this exact tape signature across four prior decisions. Deployment strategy calls for 10-15% initial position at $156-$157 with scale-in to $152-$149 on support tests, structural stop at $148.50, and breakout leg reserved for confirmed close above $162 with volume confirmation. The 12-month thesis leans slightly bullish with oil recovery as the key catalyst, while near-term asymmetry is roughly balanced with downside tilt over 1-3 months.

Outcome

–

Return

+0.17%

Status

scored

Analyst recommends buying XOM at current levels ($154-156) but defers entry until after the Jackson Hole Fed speech on Aug 28 to avoid overnight binary event risk. Initial position of 1.5% with a stop at $146 (2.9 ATR), scaling to 2.5-3% if the 50 SMA at $149.45 holds on a closing basis with RSI rotating above 50. Targets are $168 (50% trim) and $176 (30% trim), with the final 20% trailing at $165.

Outcome

–

Return

-1.11%

Status

scored

Trim 10–15% of XOM exposure near $158 rather than waiting for rallies to $160–162 or $165+, maintaining 85–90% core position. Use $149 as the structural stop-loss level, with $165 reclaim on volume as an add-back trigger and $149 break on volume as a 40–50% thesis-exit signal. Q3 2026 earnings in late October serves as the binding reassessment gate, where FCF >$12B with EPS intact at $9.50+ warrants moving to Hold, while FCF <$10B or EPS cut to <$8.50 warrants rebuilding to Sell.

Outcome

✓

Return

-1.53%

Status

scored

Analysts unanimously maintain a HOLD rating as the structural floor (200 SMA at $141, 0.17 beta, $20B buyback, 2.51% dividend) has absorbed selling through three prior Underweight tests. The critical operational change is replacing the failed $175-180 OTM covered-call overlay with protective puts at $155-160 strikes (Dec 2026 expiry) on 35-40% of position, which now sit within 3-5% of spot and directly hedge the $148-155 mean-reversion zone. Execute 20-25% trim in the $164-168 band with a hard stop at $148.77, with Q3 2026 earnings in late October serving as the binding reassessment gate.

Outcome

✗

Return

-2.08%

Status

scored

Maintain XOM at Hold with a covered-call overlay on 35-40% of the position at $175-180 strikes (Dec 2026 expiry), preserving 60-65% as core long for dividend capture and structural-floor ballast. The $148 closing basis serves as the hard stop (50 SMA/lower Bollinger/confluence level that held through three prior Underweight tests), with re-entry staging at $153, $148, and $140 on pullbacks. Q3 2026 earnings in late October is the binding reassessment gate with FCF/EPS thresholds outlined.

Outcome

✓

Return

-0.64%

Status

scored

Maintain XOM at tactical trim levels (70-75% of prior size) via covered-call overlay on 25-30% of the position at $175-180 strikes (Dec 2026 expiry) rather than market-on-close trim into supply-dense levels, honoring the binding 8/17 reflection against Underweight conviction drift while executing the 8/20 call to harvest mean reversion premium in this stretched setup (RSI 71+, 91% Bollinger, MACD compressed 65%). Hard stop on overlay-managed core at $156-158 closing basis (50 SMA zone), with Q3 2026 earnings in late October as the binding reassessment gate.

Outcome

✓

Return

-0.63%

Status

scored

XOM is rated HOLD at $166 with RSI 71.79 pinned to the upper Bollinger band after a ~40% YTD sector move, preventing fresh capital deployment despite exceptional fundamentals ($14.83B Q2 net income, $17.03B FCF, 37% forward EPS growth). A staged scaling-in framework is activated on pullbacks: 33% tranche at $161 (10 EMA), 33% at $157 (20 SMA), and final 34% at $147.80 (50 SMA), with hard stop at $147.80 and Q3 2026 earnings in late October as the binding reassessment gate.

Outcome

✓

Return

+0.84%

Status

scored

Maintain XOM at full size as structural-floor ballast (0.47x net leverage, $37B capital returns), but do not add at $164.77—stage new capital with 50% deployment only on confirmed pullback to the $156-160 zone. Hard stop at $140 (200 SMA); no tactical trim into strength. Q3 2026 earnings in late October is the binding reassessment gate; three geopolitical triggers (US-Iran diplomatic engagement, WTI below $80 weekly close, formal ceasefire/nuclear deal) would operationalize stop-tightening or trimming actions.

Outcome

✓

Return

-0.48%

Status

scored

Hold rating maintained with 15-20% tactical trim into $168-$170 strength, preserving 80-85% as strategic core for dividend capture and structural-floor ballast. The $156 closing stop governs the tactical portion while weekly closes below $147-150 with momentum deterioration invalidate the strategic position. Q3 2026 earnings in late October serves as the binding reassessment gate; optional Dec 2026 $150-155 puts provide cheap tail hedge.

Outcome

✗

Return

+2.54%

Status

scored

Underweight rating on XOM reflects a tactical trim-into-strength execution at upper Bollinger resistance ($161-162), not a directional cycle-peak conviction call. The framework trims 15-20% of exposure while preserving 80-85% as core long for the 2.6% dividend yield and structural floor support, with a hard stop at $156 and Q3 2026 earnings in late October serving as the mandatory reassessment gate based on FCF and forward EPS targets.

Outcome

✗

Return

+0.85%

Status

scored

Underweight rating maintained as a tactical trim-into-strength execution at upper Bollinger resistance ($158-162), not a directional cycle-peak conviction call; trim 25-30% laddered across resistance zones while retaining 70-75% core position for the 2.6% dividend yield, with hard stop at $155.60 and mandatory reassessment gate at Q3 earnings in October.

Outcome

✗

Return

+0.94%

Status

scored

Maintain Underweight on XOM and trim 25-30% of position on any rally into the $161-165 upper Bollinger band zone, preserving 50-60% of the prior weight as a core holding given the structural floor (12+ years dividend growth, rising 200 SMA). Hard stop at $147.42 on a closing basis; keep freed capital as dry powder for potential adds at $154-147 rather than rotating into adjacent energy names. The rating is driven by a cyclical peak argument (Q2 2026 likely the cycle top, 14.79x forward P/E on peak-cycle assumptions, 30%+ compression risk from Brent mean-reversion) combined with a parking-drift pattern across five consecutive Hold calls producing -1.8% to +4.4% alpha outcomes.

Outcome

✓

Return

-0.71%

Status

scored

Maintain XOM at Hold with current position size; the structural floor (1.37x FCF coverage, 12+ years dividend increases, investment-grade balance sheet) prevents Underweight while the 25.5%+ YTD run and 14.98x forward P/E prevent Buy. Trim 5% on declining-volume push into $161-162; tactical add zone at $154-156 (1-2% portfolio cap) with hard stop at $152 and structural invalidation at $147; use Q4 $150-strike puts if exposure exceeds 3% of portfolio; reassess at Q3 2026 earnings in late October.

Outcome

✓

Return

-0.03%

Status

scored

Maintain XOM at current position size without adding above $155.66; the structural floor (1.37x FCF coverage, 0.17 beta, intact 200 SMA) and 74% Polymarket WTI skew support holding, but BB rejection at $161.67, 50% volume contraction (19.7M → 9.9M), and 11:1.4 downside-to-upside asymmetry at $159.80 preclude adding at current levels. The $147 add zone has not triggered across four Hold calls and the 10 EMA pullback to $155.66 represents a more realistic reload opportunity.

Outcome

✓

Return

+0.01%

Status

scored

Hold XOM at current weight while harvesting the 2.69% dividend, with a dual-trigger framework: tactical add of 2-2.5% of portfolio on confirmed close above $161.62 with next-session hold on >12M volume and positive MACD, or alternatively pullback add at $152-$155 if breakout fails. Trim 10-15% on sustained push to $170+; hard stop at $146 (50 SMA) where a close below on rising volume converts to review-and-reduce.

Outcome

✗

Return

+4.41%

Status

partial

Maintain XOM at current position size with all three analysts converging on Hold, as the structural floor thesis (1.37x FCF coverage, 0.17 beta, 12+ years of dividend increases) remains intact while short-term momentum has cooled. The Neutral Analyst's defined decision tree provides execution triggers: 2% scale-in on pullback to $150-152 holding 10 EMA, full 4% add on breakout above $157 with volume >12M, and review-and-reduce if close below 50 SMA ($146.48) on rising volume.

Outcome

✓

Return

-1.16%

Status

scored

XOM is maintained at Hold with current position size as the structural floor thesis (1.37x FCF coverage, 0.17 beta, 12+ years of dividend increases, investment-grade rating) remains intact while the Q2 best-profit-in-four-years inflection and 5.5-6% total shareholder yield prevent underweight, though the 25.5% YTD run and RSI cooling from 72 to 59 limit upside asymmetry. Key monitoring levels are the 10 EMA at $153.75 (near-term warning/25-30% trim signal on close below with rising volume), the 50 SMA at $146.38 (hard invalidation stop), and $156.94 with positive MACD histogram (add trigger); reassess at Q3 earnings in October.